Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02363556 · ClinicalTrials.gov registry record · NA

Comparing Misoprostol Alone to Dilapan With Misoprostol and Comparing Buccal to Vaginal Misoprostol

A NA study, sponsored by Medstar Health Research Institute.

Completed
Registry status
NA
Development phase
160
Enrollment target

NCT02363556 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 160 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02363556, a NA study, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target

Study Summary

This randomized controlled trial will use a 2 by 2 factorial design to assess methods of cervical preparation prior to Dilation and Evacuations (D\&Es) at 14 0/7 to 19 6/7 weeks gestational age. In total, 160 woman will be randomized to misoprostol alone or Dilapan with misoprostol and separately randomized to buccal or vaginal administration of 400-mcg misoprostol. A total of 80 women will receive 400-mcg misoprostol only (40 vaginal and 40 buccal). Another 80 women will have Dilapan inserted and then use misoprostol (40 vaginal and 40 buccal). Four to six hours later, the Dilation and Evacuation (D\&E) procedure will be performed.

Interventions

  • PROCEDURE Misoprostol administered vaginally
  • PROCEDURE Misoprostol administered buccally
  • PROCEDURE Misoprostol administered vaginally with Dilapan
  • PROCEDURE Misoprostol administered buccally with Dilapan

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2015-01
Est. Completion 2017-06
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT02363556

The ClinicalTrials.gov registry entry for NCT02363556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Misoprostol administered vaginally is the first listed.

NCT02363556 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02363556 about?

NCT02363556 is a clinical study titled "Comparing Misoprostol Alone to Dilapan With Misoprostol and Comparing Buccal to Vaginal Misoprostol". This randomized controlled trial will use a 2 by 2 factorial design to assess methods of cervical preparation prior to Dilation and Evacuations (D\&Es) at 14 0/7 to 19 6/7 weeks gestational age. In total, 160 woman will be randomized to misoprostol alone or Dilapan with misoprostol and separately ra...

What is the current status of trial NCT02363556?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2015-01. Estimated completion is 2017-06.

What interventions are being tested in trial NCT02363556?

The interventions under investigation include: Misoprostol administered vaginally (PROCEDURE), Misoprostol administered buccally (PROCEDURE), Misoprostol administered vaginally with Dilapan (PROCEDURE), Misoprostol administered buccally with Dilapan (PROCEDURE).

Who is sponsoring clinical trial NCT02363556?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.